Safety, Tolerability and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Healthy Asian and Caucasian Male Volunteers

NCT02596217 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ABBV-066
DRUG: ABBV-066
DRUG: Placebo
DRUG: Placebo

Sponsor

AbbVie

Collaborators

[object Object]